These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 13996899)

  • 21. IMMUNOHISTOCHEMICAL STUDY OF THROMBOLYTIC MECHANISMS.
    BACK N; HIRAMOTO R; AMBRUS JL
    Blood; 1965 Jun; 25():1028-36. PubMed ID: 14294764
    [No Abstract]   [Full Text] [Related]  

  • 22. [STUDIES ON THE CONDITIONS FOR THE FORMATION OF URINARY CYLINDERS].
    FREY J; JUERGENS J
    Med Klin; 1964 Apr; 59():560-7. PubMed ID: 14197215
    [No Abstract]   [Full Text] [Related]  

  • 23. CURRENT STATUS OF THROMBOLYTIC THERAPY.
    SHERRY S
    Geriatrics; 1964 Sep; 19():628-43. PubMed ID: 14221883
    [No Abstract]   [Full Text] [Related]  

  • 24. [ON THE PERFORMANCE OF THROMBOLYTIC TREATMENT WITH STREPTOKINASE].
    WINCKELMANN G; HELMS M
    Med Klin; 1963 Sep; 58():1568-71. PubMed ID: 14050317
    [No Abstract]   [Full Text] [Related]  

  • 25. Assay of thrombolytic ('fibrinolytic') mixtures intended for therapeutic use.
    FLETCHER AP; ALKJAERSIG N; SHERRY S
    J Lab Clin Med; 1961 Apr; 57():620-9. PubMed ID: 13700257
    [No Abstract]   [Full Text] [Related]  

  • 26. ON THE COMBINED ADMINISTRATION OF STREPTOKINASE AND PANCREATIC TRYPSIN INHIBITOR.
    VERSTRAETE M; VERMYLEN J; VERMYLEN C; DEVREKER RA
    Thromb Diath Haemorrh; 1964 Dec; 12():391-5. PubMed ID: 14254698
    [No Abstract]   [Full Text] [Related]  

  • 27. FURTHER EXPERIENCE WITH STREPTOKINASE AS THROMBOLYTIC AGENT.
    AMERY A; VERMYLEN J; MAES H; VERSTRAETE V
    Sangre (Barc); 1964; 61():9-11. PubMed ID: 14214896
    [No Abstract]   [Full Text] [Related]  

  • 28. [THE TREATMENT OF THROMBOSES BY LOCAL INFUSION OF FIBRINOLYTIC ENZYMES].
    BENZER H; BLUEMEL G; GOTTLOB R; PIZA F
    Langenbecks Arch Klin Chir Ver Dtsch Z Chir; 1963 Nov; 304():775-80. PubMed ID: 14120202
    [No Abstract]   [Full Text] [Related]  

  • 29. AN IN VITRO STUDY OF FIBRINOLYTIC AGENTS ON V2 CARCINOMA CELLS AND INTRAVASCULAR THROMBI IN RABBITS.
    JOHNSON JH; WOODS JR
    Bull Johns Hopkins Hosp; 1963 Dec; 113():335-46. PubMed ID: 14089496
    [No Abstract]   [Full Text] [Related]  

  • 30. [TECHNIC FOR THE PREPARATION OF A FIBRINOGEN REAGENT FOR DETERMINATIONS OF FIBRINOLYTIC ACTIVITY].
    BLATRIX C; VIGNAL A; STEINBUCH M
    Hemostase; 1963; 3():179-86. PubMed ID: 14050814
    [No Abstract]   [Full Text] [Related]  

  • 31. [Research on the antifibrinolytic effect of 6-aminocaproic acid. III. Effect of 6-aminocaproic acid as an antidote to thrombolytic agents (plasmin, streptokinase)].
    GIBELLI A
    Gazz Int Med Chir; 1962 Nov; 66():2444-50. PubMed ID: 13947688
    [No Abstract]   [Full Text] [Related]  

  • 32. [PRESENT STATUS OF THROMBOLYTIC THERAPY].
    VAIREL EG; ANTOINE G
    Sangre (Barc); 1964; 41():441-6. PubMed ID: 14248832
    [No Abstract]   [Full Text] [Related]  

  • 33. THE PRESENT STATUS OF FIBRINOLYTIC THERAPY.
    CLIFFTON EE
    Angiology; 1963 Nov; 14():533-41. PubMed ID: 14075024
    [No Abstract]   [Full Text] [Related]  

  • 34. Streptokinase as a thrombolytic agent.
    JOHNSON AJ; McCARTY WR
    Am J Cardiol; 1960 Aug; 6():487-95. PubMed ID: 14407414
    [No Abstract]   [Full Text] [Related]  

  • 35. PITFALLS IN THE THROMBOLYTIC TREATMENT OF VENOUS OCCLUSION.
    AMERY A; VERMYLEN J; MAES H; VERSTRAETE M
    Vasc Dis; 1964 Mar; 1():89-93. PubMed ID: 14186547
    [No Abstract]   [Full Text] [Related]  

  • 36. In vivro studies on fibrinogenolysis induced by streptokinase.
    GODAL HC; HELLE I
    Scand J Clin Lab Invest; 1963; 15():303-10. PubMed ID: 13963230
    [No Abstract]   [Full Text] [Related]  

  • 37. [CLINICAL EXPERIENCE WITH STREPTOKINASE AS A THROMBOLYTIC AGENT].
    VERSTRAETE M; AMERY A
    Acta Cardiol; 1963; 18():235-47. PubMed ID: 14045888
    [No Abstract]   [Full Text] [Related]  

  • 38. The effectiveness of activators in clot lysis, with special reference to fibrinolytic therapy. A new method for determination of preformed clot lysis.
    BLIX S
    Acta Med Scand Suppl; 1962; 386():1-24. PubMed ID: 13971658
    [No Abstract]   [Full Text] [Related]  

  • 39. MECHANISM OF HUMAN PLASMINOGEN ACTIVATION BY STREPTOKINASE AND HUMAN PLASMIN.
    BLATT WF; GRAY JL; JENSEN H
    Thromb Diath Haemorrh; 1964 Apr; 11():85-93. PubMed ID: 14167118
    [No Abstract]   [Full Text] [Related]  

  • 40. ARE THROMBOLYTIC AGENTS MORE EFFECTIVE IF GIVEN NEAR THE THROMBUS?
    HUME M
    Lancet; 1964 Sep; 2(7358):500-1. PubMed ID: 14172918
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.